Prime Minister Justin Trudeau says the first Canadian clinical trials of a potential COVID-19 vaccine have been approved by Health Canada, and will be conducted out of the Canadian Centre for Vaccinology at Dalhousie University.
Speaking from Rideau Cottage on Saturday, he said the National Research Council of Canada (NRC) will be working with the drug’s manufacturers in order to produce and distribute the vaccine “here at home” — if the trials are successful.
“Research and development take time and must be done right,” he said. “But this is encouraging news.”
“This is the first clinical trial application in Canada for a vaccine specifically designed to prevent COVID-19,” the statement read. “This decision followed careful review of the application, which Health Canada determined met the necessary requirements for safety and quality.”